Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies

Join Dr. Adam Burgoyne, an Associate Clinical Professor at the University of California, San Diego, and Dr. Stacey Stein, an Associate Professor of Internal Medicine at Yale Medicine, New Haven, Connecticut, as they discuss the latest clinical information and provide the most accurate recommendations for treatment as members of the multidisciplinary hepatocellular carcinoma (HCC) cancer treatment team. Discover how healthcare providers can apply strategies for early and accurate diagnosis of HCC stages, analyze data on IO therapy with liver-directed therapy procedures to identify appropriate patients, and much more. If you're a healthcare provider looking to learn more about the role of HCC care team members watch and learn!
Full CME Activity: www.francefoundation.com/educ...
The France Foundation Website: www.francefoundation.com/
The Association of Community Cancer Centers Website: www.accc-cancer.org/
This activity is supported by an educational grant from AstraZeneca and is intended for medical oncologists and other members of the health care team who care for patients with hepatocellular carcinoma (HCC).